Vaccine Trials Should Reflect America’s Diversity
Racial minorities and those with underlying health conditions may be at a greater risk from coronavirus infection, but have historically been less likely to be included in clinical trials...
Racial minorities and those with underlying health conditions may be at a greater risk from coronavirus infection, but have historically been less likely to be included in clinical trials...
The assay looks for stomach, esophageal, colorectal, lung and liver malignancies
Drug manufacturers are racing to create a protective measure against coronavirus without destroying the patient’s immune system
Remote clinical trials and other changes could permanently alter pharmaceutical development
Participation rates were already low, but the pandemic threatens to drive them even lower
Rates of childhood immunization have fallen across the U.S., raising the risk of vaccine-preventable disease outbreaks
With little data on what works and what doesn’t, doctors trade tips and argue about risks
Philip W. Askenase explains why naturally occurring exosomes are better for drug discovery.
In exosomes, our bodies have an efficient means of transmitting RNA information. Researchers want to use it to deliver drugs.
Vesicles secreted by stem cells might give clinicians a safer and simpler alternative to cell therapy, but researchers are still grappling with how best to prepare and study these tiny particles...
What scientists know about the inner workings of the pathogen that has infected the world
Unlike vials, flexible films could preserve medicines for long periods, with no refrigeration needed
Some experts caution we should temper our expectations about the much-touted approach
Biotechs and pharma want to protect patients without triggering immune system havoc
Researchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good news
Mosquitoes that like to bite at night are being thwarted by bed nets, leading to the rise of populations that prefer to bite when the nets are not up yet.
Scientists urge caution over hints of success emerging from small human and animal studies
Some individuals choosing physician-assisted death donate their tissue to science.
Different species are helping answer different questions about COVID-19 in humans in order to develop vaccines and treatments
Blood tests that find malignancies before they spread could transform our approach to treatment...
You have free articles left.
Support our award-winning coverage of advances in science & technology.
Already a subscriber? Sign in.